ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2012
An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer.
Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 47 citations in OpenAlex.
- Expert consensus on optimal management of liver-related adverse events during CDK4/6 inhibitor therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Review
- Blood Pressure and Cardiovascular Risk in Women With Breast Cancer: The Pathways Heart Study.JACC. Advances · 2024Article
- Recommendations for cyclin‑dependent kinase 4/6 inhibitor treatments in the context of co‑morbidity and drug interactions (Review).Oncology letters · 2024Review
- Influence of depression on breast cancer treatment and survival: A Kentucky population-based study.Cancer · 2023Article
- Article
- Do breast cancer survivors with a recent history of clinical depression report worse experiences with care? A retrospective cohort study using SEER-CAHPS data.Cancer medicine · 2023Article
- Multimorbidity in people living with and beyond cancer: a scoping review.American journal of cancer research · 2023Article
- Age and competing concerns in treatment selection for women with non-metastatic HR+ and HER2- breast cancer: Current clinical practice.Journal of geriatric oncology · 2022Article
- Review
- Article
- Effect of omission of surgery on survival in patients aged 80 years and older with early-stage hormone receptor-positive breast cancer.The British journal of surgery · 2020Article
- Tumor characteristics and treatment outcomes of older patients with breast cancer in Jordan.BMC women's health · 2020Article
- Glycosylated Hemoglobin A1c Is Associated with Anthropometric Measurements and Tumor Characteristics in Breast Cancer Patients.International journal of women's health · 2020Article
- Toward a health-promoting system for cancer survivors: Patient and provider multiple behavior change.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2019Review
- Disease trajectories and mortality among women diagnosed with breast cancer.Breast cancer research : BCR · 2019Article
- Prescription Drug Coverage and Outcomes of Myeloma Therapy Among Medicare Beneficiaries.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2018Article
- Comorbid conditions and health-related quality of life in long-term cancer survivors-associations with demographic and medical characteristics.Journal of cancer survivorship : research and practice · 2018Article
- Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study.Journal of comorbidity · 2018Article
- Post-Treatment Survivorship Care Needs of Spanish-speaking Latinas with Breast Cancer.The Journal of community and supportive oncology · 2017Article
- Cancer Type and Risk of Newly Diagnosed Depression Among Elderly Medicare Beneficiaries With Incident Breast, Colorectal, and Prostate Cancers.Journal of the National Comprehensive Cancer Network : JNCCN · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLongitudinal analyses of comorbid conditions in women with breast cancer are few.
methodsUsing Surveillance, Epidemiology, and End Results-Medicare data, we included 51,950 women aged≥66 years with in situ and stage I to IV breast cancer diagnosed in 1998-2002. We identified the prevalence and incidence of 34 comorbid conditions in these women, as well as in a matched cohort without cancer whose rates were standardized to the age and race/ethnicity distribution of the cancer patients. We also estimated rates of office encounters and diagnostic or testing procedures during the 12 months before diagnosis.
resultsThe prevalence of most conditions at diagnosis was comparable among breast cancer and noncancer patients. New conditions after diagnosis were more common in breast cancer patients, and the incidence rates increased with higher stage at diagnosis. Before diagnosis, women presenting with stage IV disease had 41% [95% confidence interval (CI) 38% to 43%] fewer physician encounters and 34% (95% CI 24% to 31%) fewer unique diagnostic tests than women diagnosed with carcinoma in situ.
conclusionsMany comorbid conditions are identified as a consequence of the breast cancer diagnosis. There appears to be an important contribution from a lack of interaction with the health care system before diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.